Zithromax®

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

CompletedNCT00830206

Teva Pharmaceuticals USAHealthy

Start: 2006-01-31End: 2006-01-31Updated: 2024-08-20

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

CompletedNCT00830336

Teva Pharmaceuticals USAHealthy

Start: 2005-10-31End: 2005-11-30Updated: 2024-08-20